673 results on '"Furumoto, Shozo"'
Search Results
2. Transmembrane protein 106B amyloid is a potential off-target molecule of tau PET tracers in the choroid plexus
3. A Novel Near-Infrared Fluorescence Probe THK-565 Enables In Vivo Detection of Amyloid Deposits in Alzheimer’s Disease Mouse Model
4. Highlight selection of radiochemistry and radiopharmacy developments by editorial board.
5. Highlight selection of radiochemistry and radiopharmacy developments by editorial board.
6. Amyloid accumulation in cases of suspected comorbid cerebral amyloid angiopathy and isolated cortical venous thrombosis
7. Synthesis and evaluation of 2-pyrrolopyridinylquinoline derivatives as selective tau PET tracers for the diagnosis of Alzheimer's disease
8. A concentration-based microscale method for 18F-nucleophilic substitutions and its testing on the one-pot radiosynthesis of [18F]FET and [18F]fallypride
9. Skp2 dictates cell cycle-dependent metabolic oscillation between glycolysis and TCA cycle
10. Dynamic PET Measures of Tau Accumulation in Cognitively Normal Older Adults and Alzheimer’s Disease Patients Measured Using [18F] THK-5351
11. L-type amino acid transporter 1 is associated with chemoresistance in breast cancer via the promotion of amino acid metabolism
12. The neuromodulatory role of dopamine in improved reaction time by acute cardiovascular exercise
13. Validation of A Novel MAO‐B PET tracer [18F]SMBT‐1 on postmortem human brain samples
14. Radiosynthesis and evaluation of [18F]SNFT-1 for imaging early tau deposition
15. Characterization of the binding of tau imaging ligands to melanin-containing cells: putative off-target-binding site
16. Site-Specific Labeling of F-18 Proteins Using a Supplemented Cell-Free Protein Synthesis System and O-2-[18F]Fluoroethyl-L-Tyrosine: [18F]FET-HER2 Affibody Molecule
17. Tau PET in Neurodegenerative Diseases Manifesting Dementia
18. Characterization of the radiosynthesis and purification of [18F]THK-5351, a PET ligand for neurofibrillary tau
19. Tau positron emission tomography using [18F]THK5351 and cerebral glucose hypometabolism in Alzheimer's disease
20. Minimization of the amount of Kryptofix 222 - KHCO3 for applications to microscale 18F-radiolabeling
21. Development of [11C]/[3H]THK-5351 – A potential novel carbon-11 tau imaging PET radioligand
22. Regional tau deposition and subregion atrophy of medial temporal structures in early Alzheimer's disease: A combined positron emission tomography/magnetic resonance imaging study
23. Advances in the development of tau PET radiotracers and their clinical applications
24. P-098 - Radiosynthesis and evaluation of [18F]SNFT-1 for imaging early tau deposition
25. A novel near-infrared fluorescence probe THK-565 enables in vivo detection of amyloid and tau deposits in Alzheimer’s disease mouse models
26. In vivo [18F]THK-5351 imaging detected reactive astrogliosis in argyrophilic grain disease with comorbid pathology: A clinicopathological study
27. Amyloid deposits and response to shunt surgery in idiopathic normal-pressure hydrocephalus
28. Quantitative kinetic analysis of PET amyloid imaging agents [11C]BF227 and [18F]FACT in human brain
29. Full automatic synthesis of [18F]THK-5351 for tau protein PET imaging in Alzheimer’s disease patients: 1 year experience
30. A comparison of five partial volume correction methods for Tau and Amyloid PET imaging with [18F]THK5351 and [11C]PIB
31. Author Correction: Skp2 dictates cell cycle-dependent metabolic oscillation between glycolysis and TCA cycle
32. モノアミン酸化酵素BとPET リガンド[18F]SMBT-1/[18F]THK5351複合体の結晶構造解析
33. Case of progressive supranuclear palsy detected by tau imaging with [18F]THK‐5351 before the appearance of characteristic clinical features
34. Neuroimaging-pathological correlations of [18F]THK5351 PET in progressive supranuclear palsy
35. Characterization of the radiolabeled metabolite of tau PET tracer 18F-THK5351
36. Preclinical Evaluation of [18F]THK-5105 Enantiomers: Effects of Chirality on Its Effectiveness as a Tau Imaging Radiotracer
37. Imaging of Tau Pathology in a Tauopathy Mouse Model and in Alzheimer Patients Compared to Normal Controls
38. [18F]-THK5351 PET Imaging in Patients With Semantic Variant Primary Progressive Aphasia
39. Evaluation of 18F labeled glial fibrillary acidic protein binding nanobody and its brain shuttle peptide fusion proteins using a neuroinflammation rat model.
40. Rapid biochemical synthesis of 11C-labeled single chain variable fragment antibody for immuno-PET by cell-free protein synthesis
41. [18F]THK-5117 PET for assessing neurofibrillary pathology in Alzheimer’s disease
42. Synthesis of [ 11C]interleukin 8 using a cell-free translation system and l-[ 11C]methionine
43. Reactivity of electrochemically concentrated anhydrous [ 18F]fluoride for microfluidic radiosynthesis of 18F-labeled compounds
44. Highlight selection of radiochemistry and radiopharmacy developments by editorial board
45. Imaging of Reactive Astrogliosis by Positron Emission Tomography
46. Tau PET Imaging in Alzheimer’s Disease
47. In vivo evaluation of a novel tau imaging tracer for Alzheimer’s disease
48. Analysis of early phase [11C]BF-227 PET, and its application for anatomical standardization of late-phase images for 3D-SSP analysis
49. Use of a Benzimidazole Derivative BF-188 in Fluorescence Multispectral Imaging for Selective Visualization of Tau Protein Fibrils in the Alzheimer’s Disease Brain
50. Electrochemical concentration of no-carrier-added [ 18F]fluoride from [ 18O]water in a disposable microfluidic cell for radiosynthesis of 18F-labeled radiopharmaceuticals
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.